GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (XTAE:BOLT) » Definitions » Price-to-Funds-From-Operations

BioLight Life Sciences (XTAE:BOLT) Price-to-Funds-From-Operations : (As of May. 14, 2024)


View and export this data going back to 2005. Start your Free Trial

What is BioLight Life Sciences Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


BioLight Life Sciences (XTAE:BOLT) Business Description

Traded in Other Exchanges
N/A
Address
Kiryat Atidim, Building 7, Entrance 1, 2nd Floor, Tel-Aviv, ISR, 6158101
BioLight Life Sciences Ltd is an emerging global ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.